ArticleBiomaterials2023

Nanovaccine that activates the NLRP3 inflammasome enhances tumor specific activation of anti-cancer immunity.

Saikat Manna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.